L2L Microarray Analysis Tool
Results for J01A.profile.ud50
| Results summary | View all lists in L2L MDB | View all genes in J01A.profile.ud50 |
| List Name | Description | Total probes |
Expected matches |
Actual matches |
Fold Enrichment |
Binomial p-value |
|---|---|---|---|---|---|---|
| vhl_rcc_up | Upregulated in VHL-null renal carcinoma cells vs. VHL-rescued (Fig. 1a+b) | 153 | 0.76 | 6 | 7.93 | 1.27e-04 |
| gh_exogenous_early_dn | Down-regulated at early time points (1-4 hours) following treatment of mammary carcinoma cells (MCF-7) with exogenous human growth hormone | 14 | 0.07 | 2 | 28.90 | 2.14e-03 |
| uvc_ttd_4hr_dn | Down-regulated at 4 hours following treatment of XPB/TTD fibroblasts with 3 J/m^2 UVC | 641 | 3.17 | 9 | 2.84 | 5.25e-03 |
| uvc_ttd_all_dn | Down-regulated at any timepoint following treatment of XPB/TTD fibroblasts with 3 J/m^2 UVC | 780 | 3.86 | 10 | 2.59 | 6.26e-03 |
| vegf_huvec_up | 20 genes with the largest fold-change up-regulation at any time point (30min to 24 hours) after VEGF treatment in human umbilical vein endothelial cells | 24 | 0.12 | 2 | 16.86 | 6.28e-03 |
| uvc_ttd-xpcs_common_dn | Down-regulated at any timepoint following treatment of both XPB/CS and XPB/TTD fibroblasts with 3 J/m^2 UVC | 344 | 1.70 | 6 | 3.53 | 7.84e-03 |